Research Scientists

Robert P. Schwartz

Robert P. Schwartz
Medical Director/Senior Research Scientist

Degree: M.D., University of Padua, Italy
Phone: 410-837-3977 ext. 276
Fax: 410-752-4218
Email:


Research Interests

Dr. Schwartz, FRI’s Medical Director, is an addiction psychiatrist and former Director of the Division of Alcohol and Drug Abuse in the Department of Psychiatry at the University of Maryland School of Medicine. His research interests include entry and engagement in drug abuse treatment, pharmacotherapy of opioid dependence, and health services research. He is Principal Investigator of two National Institute on Drug Abuse (NIDA) funded clinical trials examining: (1) a novel approach to re-engineering the clinical structure of methadone treatment as compared to standard treatment delivery; and, (2) Screening, Brief Intervention Referral to Treatment (SBIRT) in New Mexico in which a brief intervention is provided by a counselor as compared to a novel computer program. He is Co-Investigator on a study examining buprenorphine for re-entering prisoners and is the Co-Principal Investigator (with Dr. Maxine Stitzer from Johns Hopkins University) on the Mid-Atlantic Node of the NIDA Clinical Trials Network. Dr. Schwartz serves on the NIH Center for Scientific Review’s Health Services Organization and Delivery Study Section.

Selected Publications

Gordon, M.S., Kinlock, T.W., Schwartz, R.P., Couvillion, K.A., Sudec, L.J., O’Grady, K.E., & Vocci, F.J. (in press). Buprenorphine treatment for probationers and parolees. Substance Abuse.

Bellamoli, E., Manganotti, P., Schwartz, R. P., Rimondo, C., Gomma, M., & Serpelloni, G. (in press). rTMS in the treatment of drug addiction: An update about human studies. Behavioural Neurology.

Blanco, C., Rafful, C., Wall, M. W., Jin, C. J., Kerridge, B., & Schwartz, R. P. (in press). The latent structure and predictors of non medical prescription drug use and prescription drug use disorders: A National Study. Drug and Alcohol Dependence.

Gordon, M. S., Kinlock, T. W., Couvillion, K. A., Schwartz, R. P., Wilson, M. E., & O’Grady, K. E. (in press). Gender differences among prisoners with pre-incarceration heroin dependence participating in a randomized clinical trial of buprenorphine treatment. Journal of Offender Rehabilitation.

Gordon, M. S., Kinlock, T. W., Schwartz, R. P., Couvillion, K., Schwartz, R. P., & O'Grady, K. E. (in press). The severity, frequency and variety of crime in heroin-dependent prisoners enrolled in a buprenorphine clinical trial. The Prison Journal.

Kinlock, T. W., Gordon, M. S., Schwartz, R. P., & O’Grady, K. E. (in press). Individual patient and program factors related to prison and community treatment completion in prison-initiated methadone maintenance treatment (MMT). Journal of Offender Rehabilitation.

Schwartz, R. P., Gryczynski, J., O’Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., Mitchell, S. G., & Jaffe, J. H. (in press). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland from 1995-2009. American Journal of Public Health.

Blanco, C., Iza, M., Schwartz, R. P., Rafful, C., Wang, S., & Olfson, M. (2013). Probability and predictors of treatment seeking for prescription opioid use disorders: a national study. Drug and Alcohol Dependence, 131(1-2), 143-148.

Defulio, A., Stitzer, M., Roll, J., Petry, N., Nuzzo, P., Schwartz, R. P., & Stabile, P. (2013). Criminal justice referral and incentives in outpatient substance abuse treatment. Journal of Substance Abuse Treatment, 45(1), 70-75.

Gryczynski, J., Jaffe, J. H., Schwartz, R. P., Dusek, K. A., Gugsa, N., Monroe, C. L., O’Grady, K. E., Olsen, Y. K., & Mitchell, S. G. (2013). Patient perspectives on choosing buprenorphine over methadone in an urban equal access system. American Journal on Addictions, 22(3), 285-291.

Gryczynski, J., Mitchell, S. G., Jaffe, J. H., Kelly, S. M., Myers, C., O'Grady K. E., Olsen, Y. K., & Schwartz, R. P. (2013). Retention in methadone and buprenorphine treatment among African Americans. Journal of Substance Abuse Treatment, 45(3), 287-292.

Kelly, S. M., O'Grady K, E., Jaffe, J. H., Gandhi, D., & Schwartz, R. P. (2013). Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment. Journal of Addiction Medicine, 7(2), 133-138.

Mitchell, S. G., Gryczynski, J., O'Grady, K. E., & Schwartz, R. P. (2013). SBIRT for adolescent drug and alcohol use: Current status and future directions. Journal of Substance Abuse Treatment, 44(5), 463-472.

Schwartz, R. P., Stitzer, M. L., Feaster, D. J., Korthuis P. T., Alvanzo, A. H., Winhusen, T. M., Donnard, L., Snead, N., Metsch, L. R. (2013). HIV rapid testing in drug treatment: Comparison across treatment modalities. Journal of Substance Abuse Treatment, 44(4):369-74

Schwartz, R. P., Kelly, S. M., O’Grady, K. E., Gandhi, D., & Jaffe, J. H. (2012). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction, 107, 943-952. PMCID: PMC3319854.

Mitchell, S. G., Gryczynski, J., Peterson, T., Gonzales, A., Moseley, A., & Schwartz, R. P. (2012). Screening, brief intervention, and referral to treatment (SBIRT) for substance use in a school-based program: Services and outcomes. American Journal on Addictions, 21, S5-S13.

Mitchell, S. G., Gryczynski, J., Schwartz, R. P., O’Grady, K. E., Olsen, Y., Jaffe, J. H. (2012). A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans. Drug and Alcohol Dependence, 128(3), 222-229

Friedmann, P. D., Schwartz, R. P. (2012). Just call it “treatment.” Addiction Science & Clinical Practice, 7(1), 10.

Gonzales, A., Westerberg V. S., Peterson, T., Moseley, A., Gryczynski, J., Mitchell, S. G., Buff, G., Schwartz, R. P. (2012). Implementing a state-wide SBIRT service in rural health settings: New Mexico SBIRT. Substance Abuse. 33(2):114-23. PMCID: PMC3325793.

Gryczynski, J., Kinlock, T. W., Kelly, S. M., O’Grady, K. E., Gordon, M. S., & Schwartz, R. P. (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime. Substance Abuse, 33(1), 30-39.

Kelly, S. M., Schwartz, R. P., O’Grady, K. E., Gandhi, D., & Jaffe, J. H. (2012). Impact of methadone with v. without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial. Journal of Addiction Medicine, 6(2), 45-152. PMCID: PMC3322294.

Mitchell, S. G., Kelly, S. M., Brown, B. S., O’Grady, K. E., Schwartz, R. P. (2012). HIV sex-risk behaviors among in- v. out-of treatment heroin-addicted adults. The American Journal of Drug and Alcohol Abuse, 38(4), 328-333.

Mitchell, S. G., Kelly, S. M., Gryczynski, J., Myers, C. P., Jaffe, J. H., O’Grady, K. E., Olson, Y. K., & Schwartz, R. P. (2012). African-American patients seeking treatment in the public sector: Characteristics of buprenorphine v. methadone patients. Drug and Alcohol Dependence, 122, 55-60. PMCID: PMC3251709.

Coviello, D. M., Cornish, J. W., Lynch, K. G., Boney, T. Y., Clark, C. A., Lee, J. D., Friedmann, P. D., Nunez, E. D., Kinlock, T. W., Gordon, M. S., Schwartz, R. P., & O’Brien, C. P. (2012). A multi-site pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Substance Abuse, 33(1), 48-59.

Gryczynski, J., Mitchell, S. G., Peterson, T., Gonzales, A., Moseley, A., & Schwartz, R. P. (2011). The relationships between services delivered and substance use outcomes in New Mexico’s Screening, Brief Intervention, Referral and Treatment (SBIRT) Initiative. Drug and Alcohol Dependence, 118(2-3), 152-157. PMCID: PMC3158968. Abstract

Gryczynski J, Schwartz R. P., Salkever D. S., Mitchell S.G., Jaffe J. H. (2011). Patterns in admission delays to outpatient methadone treatment in the US. Journal of Substance Abuse Treatment, 41(4), 431-9. [PMCID: PMC3205308].

Katz, E. C., Brown, B. S., Schwartz, R. P., O’Grady, K. E., King, S. D., & Gandhi, D. (2011). Transitioning opioid-dependent patients from detoxification to long-term treatment: Efficacy of intensive role induction. Drug and Alcohol Dependence, 117(1), 24-30.

Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence, 117(2-3), 170-175.

Schwartz, R. P., Kelly, S. M., O’Grady, K. E., Gandhi, D., & Jaffe, J. H. (2011). Interim methadone treatment compared to standard methadone treatment: 4-Month findings. Journal of Substance Abuse Treatment, 41(1), 21-29. PMCID: PMC3110526.

Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Mitchell, S. G., & Brown, B. S. (2011). Antecedents and correlates of methadone treatment entry: A comparison of out-of-treatment and in-treatment cohorts. Drug and Alcohol Dependence, 115(1-2), 23-9. PMCID: PMC3059350.

Kelly, S. M., O'Grady, K. E., Brown, B. S., Mitchell, S. G., & Schwartz, R. P. (2010). The role of patient satisfaction in methadone treatment. American Journal of Drug and Alcohol Abuse, 36(3), 150-154. [PMCID: PMC2938880]. Abstract

Kelly, S. M., O'Grady, K. E., Schwartz, R. P., Peterson, J. A., Wilson, M. E., & Brown, B. S. (2010). The relationship of social support to treatment entry and engagement: The community assessment inventory. Substance Abuse, 31(1), 43-52 [PMCID: PMC2856126].

Kinlock T. W., Gordon M. S., Schwartz R. P., Fitzgerald T. T. (2010) Developing and Implementing a New Prison-Based Buprenorphine Treatment Program. Journal of Offender Rehabilitation, 49(2), 91-109. [PMCID: PMC2868193].

Peterson, J. A., Schwartz, R. P., Mitchell, S. G., Reisinger, H. S., Kelly, S. A., O'Grady, K. E., Brown, B. S., & Agar, M. H. (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy, 21, 36-42 [PMCID: PMC2790538]. Abstract

Wilson M. E., Schwartz R. P., O'Grady K. E., Jaffe J. H. (2010) Impact of interim methadone maintenance on HIV risk behaviors. Journal of Urban Health, 87(4), 586-91. [PMCID: PMC2900571].

Gryczynski, J., Schwartz, R. P., O'Grady, K., & Jaffe, J. H. (2009). Treatment entry among individuals on a waiting list for methadone maintenance. American Journal of Drug & Alcohol Abuse, 35(5), 290-294. Abstract

Gryczynski, J., Schwartz, R. P., O'Grady, K., & Jaffe, J. H. (2009). Dropout from interim methadone and subsequent comprehensive methadone maintenance. American Journal of Drug & Alcohol Abuse, 35, 394-398. Abstract

Kelly, S. M., Schwartz, R. P., O'Grady, K. E., Mitchell, S. G., Reisinger, H. S., Peterson, J. A., Agar, M. H., & Brown, B. S. (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals. The American Journal of Drug and Alcohol Abuse, 35, 38-42. Abstract

Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O'Grady, K. E. (2009). Methadone maintenance for prisoners: Results at twelve-months post-release. Journal of Substance Abuse Treatment, 37, 277-285. Abstract

Mitchell, S. G., Kelly, S. M., Brown, B. S., Reisinger, H. S., Peterson, J. A., Ruhf, A., Agar, M. H., O’Grady, K. E.& Schwartz, R. P. (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.  The American Journal on Addiction, 18(5), 346-355. Abstract

Mitchell, S. G., Kelly, S. M., Brown, B. S., Reisinger, H. S., Peterson, J. A., Ruhf, A., Agar, M. H., & Schwartz, R. P. (2009). Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users. Journal of Psychoactive Drugs, 41(2), 145-152. Abstract

Reisinger, H. S., Schwartz, R. P., Mitchell, S. G., Peterson, J. A., Kelly, S. M., O'Grady, K. E., Marrari, E. A., Brown, B. S., & Agar, M. H. (2009). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs. 41(3), 285-296. Abstract

Schwartz, R. P, Jaffe J. H., O'Grady, K. E., Kinlock, T. W., Gordon, M. S., Kelly, S. M., Wilson, M. E., & Ahmed, A. (2009). Interim Methadone Treatment: Impact on Arrests. Drug and Alcohol Dependence, 103, 148-154. Abstract

Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Mitchell, S. G., Peterson, J. A., Reisinger, H. S., Agar, M. H., & Brown, B. S. (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. The American Journal on Addictions, 17(5), 396-401. Abstract

Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Peterson, J. A., Reisinger, H. S., Mitchell, S. G., Wilson, M. E., Agar, M. H. & Brown, B. S. (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. The American Journal of Drug and Alcohol Abuse, 34(1), 17-28. Abstract

Schwartz, R. P., Highfield, D. A., Jaffe, J. H., Callaman, J. M., O'Grady, K. E. (2007). A randomized controlled trial of interim methadone maintenance: 10 month-follow-up. Drug and Alcohol Dependence, 86, 30-36. Abstract

Schwartz, R. P., McKenzie, M., Rich J. D. (2007). Opioid addiction and incarceration: an overview. Medicine and Health/Rhode Island, 90, 157-158.

Highfield, D. A., Schwartz, R. P., Jaffe, J. H., Callaman, J., O'Grady, K. E. (2007). Intravenous and intranasal heroin dependent treatment seekers: Similarities and differences. Addiction, 102(11), 1816-23. Abstract

Katz, E. C., Brown, B. S., Schwartz, R. P., King, S. D., Weintraub, E., Barksdale, W. (2007). Impact of role induction on long-term drug treatment outcomes. Journal of Addictive Diseases, 26, 81-90. Abstract

Albizu-Garcia, C., Caraballo Correa G., Hernandez Viver, A. D., Kinlock, T. W., Gordon, M. S., Antron Avila, C., Colón Reyes, I., Schwartz, R. P. (2007). Buprenorphine-Naloxone Treatment for Pre-release Opioid Dependent Inmates in Puerto Rico. Journal of Addiction Medicine, 1(6), 126-132. Abstract